当前位置：
X-MOL 学术
›
Clin. Infect. Dis.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Safety and Tolerability of Paxlovid (Nirmatrelvir/Ritonavir) in High-risk Patients.
Clinical Infectious Diseases ( IF 8.2 ) Pub Date : 2022-11-30 , DOI: 10.1093/cid/ciac588 Bryan Pesko 1, 2 , Alexandra Deng 2 , Jeannie D Chan 2, 3, 4 , Santiago Neme 4 , Shireesha Dhanireddy 4 , Rupali Jain 1, 2, 4
中文翻译：
Paxlovid（Nirmatrelvir/Ritonavir）在高危患者中的安全性和耐受性。
更新日期：2022-07-23
Clinical Infectious Diseases ( IF 8.2 ) Pub Date : 2022-11-30 , DOI: 10.1093/cid/ciac588 Bryan Pesko 1, 2 , Alexandra Deng 2 , Jeannie D Chan 2, 3, 4 , Santiago Neme 4 , Shireesha Dhanireddy 4 , Rupali Jain 1, 2, 4
Affiliation
中文翻译：
Paxlovid（Nirmatrelvir/Ritonavir）在高危患者中的安全性和耐受性。
京公网安备 11010802027423号